Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. drugmaker's respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer treatment.

#Reuters #pharma #pharmaceuticals #healthcare #Merck #MSD #lungtherapy #respiratory #Verona #FT #VeronaPharma #lungdiseases #FinancialTimes #inhalable #nonsteroidtreatment #Ohtuvayre #patients #chronicobstructivepulmonarydisease #COPD #Ohtuvayretherapy
www.reuters.com/business/hea...